Literature DB >> 3910494

Measurement of free insulin concentrations: the influence of the timing of extraction of insulin antibodies.

I Hanning, P D Home, K G Alberti.   

Abstract

Plasma insulin concentrations of insulin-treated diabetic patients must be measured after removal of insulin antibodies, usually by precipitation with polyethylene glycol (PEG). Details of the procedure vary between laboratories; commonly, frozen plasma is thawed and incubated at 37 degrees C to restore a presumed equilibrium between free and antibody bound insulin before extraction. The present study was designed to investigate methodological factors that could affect the measured free insulin concentration. In normal subjects PEG extraction of globulins did not disturb measurement of insulin concentrations, whether carried out after incubation for 2 h at 37 degrees C, or storage at -20 degrees C, in either order. Freezing or incubation of PEG extracts of plasma from insulin-treated patients also failed to disturb the measured concentrations of free insulin. When plasma from patients was incubated for 2 h after storage, a marked scatter (51-272%) of measured results occurred when compared to bedside extraction. This problem was not overcome by buffering with HEPES or storage at a lower temperature (-40 degrees C). Incubation at 0 degrees C also severely disturbed the apparent concentrations. Incubation of plasma before extraction and freezing also disturbed the measured result, a problem not corrected by maintaining near physiological pH. Total insulin concentrations measured on acid extracts were not disturbed by any of these manoeuvres. The temperature of centrifugation of blood at the time of venepuncture did not influence the result.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3910494     DOI: 10.1007/bf00291073

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

Review 1.  THE PRESENT STATUS OF INSULIN ANTAGONISTS IN PLASMA: OCTOBER 1963.

Authors:  S A BERSON; R S YALOW
Journal:  Diabetes       Date:  1964 May-Jun       Impact factor: 9.461

2.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

3.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

4.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.

Authors:  B Desbuquois; G D Aurbach
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

5.  Determination of free and antibody-bound insulin in insulin treated diabetic patients.

Authors:  L G Heding
Journal:  Horm Metab Res       Date:  1969-05       Impact factor: 2.936

6.  Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.

Authors:  J S Soeldner; D Slone
Journal:  Diabetes       Date:  1965-12       Impact factor: 9.461

7.  An immunochemical method for the quantitation of insulin antibodies.

Authors:  W G Reeves; U Kelly
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

8.  Equilibrium binding assay and kinetic characterization of insulin antibodies.

Authors:  J Goldman; D Baldwin; W Pugh; A H Rubenstein
Journal:  Diabetes       Date:  1978-06       Impact factor: 9.461

9.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

10.  Determination of free and total insulin and C-peptide in insulin-treated diabetics.

Authors:  H Kuzuya; P M Blix; D L Horwitz; D F Steiner; A H Rubenstein
Journal:  Diabetes       Date:  1977-01       Impact factor: 9.461

View more
  21 in total

1.  Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

Authors:  R Giannarelli; P Marchetti; M Giannecchini; G Di Cianni; P Cecchetti; A Masoni; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

2.  Metabolic characteristics of autoimmune diabetes mellitus in adults.

Authors:  L C Groop; J Eriksson; A Ekstrand; A Franssila-Kallunki; C Saloranta; A Miettinen
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

3.  A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules.

Authors:  L D Monti; E P Sandoli; V C Phan; P M Piatti; S Costa; A Secchi; G Pozza
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

4.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

5.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

6.  Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes.

Authors:  D Kerr; I A Macdonald; S R Heller; R B Tattersall
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

7.  Glucose counterregulation in type 1 diabetic patients with decreased symptoms of hypoglycemia after insulin pump treatment.

Authors:  A Hübinger; K Wiefels; D Ziegler; F A Gries
Journal:  Klin Wochenschr       Date:  1991-10-31

8.  Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.

Authors:  C Catalano; P H Winocour; T H Thomas; M Walker; C F Sum; R Wilkinson; K G Alberti
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

9.  Effects of differing antecedent increases of plasma cortisol on counterregulatory responses during subsequent exercise in type 1 diabetes.

Authors:  Shichun Bao; Vanessa J Briscoe; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

10.  Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study.

Authors:  Philippa J Talmud; Aroon D Hingorani; Jackie A Cooper; Michael G Marmot; Eric J Brunner; Meena Kumari; Mika Kivimäki; Steve E Humphries
Journal:  BMJ       Date:  2010-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.